Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



David Kneen

David Kneen

VP, Cell Therapy, Invetech
David leads Invetech’s global Cell Therapy business, having supported the group since 2003.  His expertise is in biotechnology commercialization and business strategy, focused particularly on the commercial-scale manufacture of cell therapies.  For the past six years he has delivered commercial cell therapy manufacturing automation programs for clients across the USA, Europe and Asia. David previously worked as a management consultant with McKinsey & Company, where he advised on a broad range of strategic and operations themes across industries including healthcare, finance and primary industry. David has an MBA from Melbourne Business School and a BE/BSc from The University of Melbourne. He is based in Invetech’s Melbourne, Australia office
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd